On 2025-05-12, Jasper Therapeutics, Inc. (JSPR) announced earnings per share of $-1.41 for the fiscal quarter ending 2025-03-31, missing the average analyst estimate of $-1.17.
The next expected annoucement date for quarterly earnings is 2025-08-12, with an average estimated earnings per share of $-1.27 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-12 | 2025-03-31 | $-1.17 | $-1.41 |
| 2025-02-27 | 2024-12-31 | $-1.27 | $-1.62 |
| 2024-11-07 | 2024-09-30 | $-1.09 | $-1.24 |
| 2024-08-13 | 2024-06-30 | $-1.09 | $-0.97 |
| 2024-05-14 | 2024-03-31 | $-1.26 | $-1.03 |
| 2024-03-04 | 2023-12-31 | $-1.65 | $-1.50 |
| 2023-11-09 | 2023-09-30 | $-1.50 | $-1.60 |
| 2023-08-11 | 2023-06-30 | $-1.30 | $-1.50 |
| 2023-05-12 | 2023-03-31 | $-1.50 | $-1.60 |
| 2023-03-08 | 2022-12-31 | $-3.70 | $-3.60 |
| 2022-11-10 | 2022-09-30 | $-3.50 | $-3.20 |
| 2022-08-12 | 2022-06-30 | $-2.90 | $-2.90 |
| 2022-05-12 | 2022-03-31 | $-3.60 | $-3.50 |
| 2021-11-12 | 2021-09-30 | $-2.80 | $-20.30 |